New CAR-T cells that attack atypical solid cancer antigens
Carina Biotech is developing CAR-T cells targeted at molecular markers found on a broad range of cancer types but with little expression on healthy cells. Carina has lead CAR-T cells
CAR-T access technologies
Creating our targeted and cytotoxic CAR-T cells is only one part of our effort to produce a broad-spectrum CAR-T therapy. Carina Biotech scientists are working on 2 complementary technologies to significantly